XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.3

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Jun. 30, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Dec. 31, 2021
--- | --- | --- | --- | --- | --- | ---
Investments at cost |  | $ 754,814 |  | $ 721,248 |  |  |
Investments at fair value |  | 729,053 |  | 720,026 |  |  |
Biotechnology Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 158,953 |  | 193,372 |  |  |
Investments at fair value |  | 139,935 |  | 195,006 |  |  |
Medical Device Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 140,172 |  | 132,803 |  |  |
Investments at fair value |  | 139,039 |  | 135,960 |  |  |
Communications Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 21,057 |  | 22,892 |  |  |
Investments at fair value |  | 24,317 |  | 26,176 |  |  |
Software Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 164,903 |  | 120,157 |  |  |
Investments at fair value |  | 161,258 |  | 118,716 |  |  |
Other Sustainability Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 89,395 |  | 84,633 |  |  |
Investments at fair value |  | 83,476 |  | 85,524 |  |  |
Diagnostics Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 9,971 |  | 9,851 |  |  |
Investments at fair value |  | 9,939 |  | 9,858 |  |  |
Other Healthcare Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 102 |  | 7,559 |  |  |
Investments at fair value |  | 1,379 |  | 3,870 |  |  |
Data Storage Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 417 |  | 476 |  |  |
Investments at fair value |  | 1,070 |  | 1,316 |  |  |
Internet and Media Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 329 |  | 329 |  |  |
Investments at fair value |  | 1,615 |  | 1,159 |  |  |
Networking Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 6,671 |  | 11,831 |  |  |
Investments at fair value |  | 6,558 |  | 11,710 |  |  |
Power Management Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,585 |  | 1,585 |  |  |
Investments at fair value |  | 2,901 |  | 2,610 |  |  |
Semiconductor Sector [Member] |  |  |  |  |  |  |
Investments at cost |  | 56 |  | 56 |  |  |
Investments at fair value |  | 0 |  | 0 |  |  |
Software, Healthcare Information and Service [Member] |  |  |  |  |  |  |
Investments at cost |  | 50,847 |  | 13,735 |  |  |
Investments at fair value |  | 50,971 |  | 14,044 |  |  |
Evelo Biosciences, Inc. [Member] |  |  |  |  |  |  |
Investments at fair value |  | 8,500 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] |  |  |  |  |  |  |
Investments at cost |  | 700,932 |  | 721,248 |  |  |
Investments at fair value |  | 695,423 |  | 720,026 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 676,864 |  | 701,074 |  |  |
Investments at fair value |  | 663,399 |  | 686,458 |  |  |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 7,211 |  | 4,184 |  |  |
Investments at fair value |  | 4,735 |  | 2,556 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 15,657 |  | 14,790 |  |  |
Investments at fair value |  | 26,189 |  | 29,712 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Long-Term Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,200 |  | 1,200 |  |  |
Investments at fair value |  | 1,100 |  | 1,300 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 88,394 |  |  |  |  |
Investments at fair value |  | 82,643 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 1,001 |  |  |  |  |
Investments at fair value |  | $ 833 |  |  |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Ceiling |  |  |  |  |  |  |
Investments at cost |  | $ 282,962 |  | 268,468 |  |  |
Investments at fair value |  | 278,989 |  | 259,366 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 9,744 |  | 9,249 |  |  |
Investments at fair value |  | 16,313 |  | 16,148 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 245,317 |  | 318,172 |  |  |
Investments at fair value |  | 241,576 |  | 317,568 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 4,197 |  |  |
Investments at fair value |  |  |  | $ 9,792 |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Sector [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 60,191 |  | $ 30,729 |  |  |
Investments at fair value |  | 60,191 |  | 25,819 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 729 |  | 416 |  |  |
Investments at fair value |  | 2,098 |  | 1,953 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 4,183 |  |  |  |  |
Investments at fair value |  | $ 6,945 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 83,705 |  |  |
Investments at fair value |  |  |  | 83,705 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 928 |  |  |
Investments at fair value |  |  |  | $ 1,819 |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,903 |  | 4,891 |  |  |
Investments at fair value |  | $ 4,903 |  | $ 4,891 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,975 |  | 4,963 |  |  |
Investments at fair value |  | 4,975 |  | 4,963 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 214 |  | 214 |  |  |
Investments at fair value |  | $ 348 |  | $ 335 |  |  |
Number of Shares (in shares) |  | 7,404 |  | 7,404 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 250 |  | $ 250 |  |  |
Investments at fair value |  | $ 250 |  | $ 250 |  |  |
Number of Shares (in shares) |  | 1,162 |  | 1,162 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,000 |  | $ 3,000 |  |  |
Investments at cost |  | 2,985 |  | 2,978 |  |  |
Investments at fair value |  | $ 2,985 |  | $ 2,978 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,975 |  | 4,963 |  |  |
Investments at fair value |  | $ 4,975 |  | $ 4,963 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,975 |  | 4,963 |  |  |
Investments at fair value |  | $ 4,975 |  | $ 4,963 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.50% |  |  |
Margin |  | 4.75% |  | 6.05% |  |  |
Floor |  | 9.55% |  | 9.55% |  |  |
Ceiling |  | 13.50% |  | 13.50% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,000 |  | $ 3,000 |  |  |
Investments at cost |  | 2,985 |  | 2,978 |  |  |
Investments at fair value |  | $ 2,985 |  | $ 2,978 |  |  |
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,468 |  | 3,360 |  |  |
Investments at fair value |  | $ 1,749 |  | $ 3,360 |  |  |
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,468 |  | 3,460 |  |  |
Investments at fair value |  | 1,749 |  | 3,460 |  |  |
Investment, Unaffiliated Issuer [Member] | Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 16 |  | 16 |  |  |
Investments at fair value |  | $ 0 |  | $ 16 |  |  |
Number of Shares (in shares) |  | 86,066 |  | 86,066 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.00% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 6,875 |  | $ 7,500 |  |  |
Investments at cost |  | 6,840 |  | 7,455 |  |  |
Investments at fair value |  | $ 6,840 |  | $ 7,455 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.00% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 6,875 |  | $ 7,500 |  |  |
Investments at cost |  | 6,840 |  | 7,455 |  |  |
Investments at fair value |  | 6,840 |  | 7,455 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 46 |  | 46 |  |  |
Investments at fair value |  | $ 69 |  | $ 67 |  |  |
Number of Shares (in shares) |  | 1,991 |  | 1,991 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.00% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 6,875 |  | $ 7,500 |  |  |
Investments at cost |  | 6,840 |  | 7,455 |  |  |
Investments at fair value |  | 6,840 |  | $ 7,455 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Convertible Debt Securities [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2023 |  |  |
Principal Amount |  |  |  | $ 250 |  |  |
Investments at cost |  |  |  | 250 |  |  |
Investments at fair value |  |  |  | $ 306 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Technology Sector [Member] | Preferred Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 261 |  |  |  |  |
Investments at fair value |  | $ 306 |  |  |  |  |
Number of Shares (in shares) |  | 1,810 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.00% |  | 14.00% |  |  |
Margin |  | 6.50% |  | 6.50% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 6,550 |  | $ 6,500 |  |  |
Investments at cost |  | 6,432 |  | 6,347 |  |  |
Investments at fair value |  | $ 6,377 |  | $ 6,347 |  |  |
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.00% |  | 14.00% |  |  |
Margin |  | 6.50% |  | 6.50% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 6,046 |  | $ 6,000 |  |  |
Investments at cost |  | 5,937 |  | 5,859 |  |  |
Investments at fair value |  | 5,886 |  | 5,859 |  |  |
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 455 |  | 455 |  |  |
Investments at fair value |  | $ 54 |  | $ 197 |  |  |
Number of Shares (in shares) |  | 516,732 |  | 516,732 |  |  |
Investment, Unaffiliated Issuer [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.00% |  | 14.00% |  |  |
Margin |  | 6.50% |  | 6.50% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 2,519 |  | $ 2,500 |  |  |
Investments at cost |  | 2,472 |  | 2,436 |  |  |
Investments at fair value |  | 2,451 |  | $ 2,436 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 10,000 |  |  |
Investments at cost |  |  |  | 9,872 |  |  |
Investments at fair value |  |  |  | $ 9,872 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 15,000 |  |  |
Investments at cost |  |  |  | 14,808 |  |  |
Investments at fair value |  |  |  | 14,808 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 126 |  |  |
Investments at fair value |  |  |  | $ 125 |  |  |
Number of Shares (in shares) |  |  |  | 463,915 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 6,000 |  |  |
Investments at cost |  |  |  | 5,923 |  |  |
Investments at fair value |  |  |  | $ 5,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 6,000 |  |  |
Investments at cost |  |  |  | 5,923 |  |  |
Investments at fair value |  |  |  | $ 5,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 4,000 |  |  |
Investments at cost |  |  |  | 3,949 |  |  |
Investments at fair value |  |  |  | $ 3,949 |  |  |
Investment, Unaffiliated Issuer [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 11.75% |  |  |
Margin |  |  |  | 4.75% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.25% |  |  |
Maturity Date |  |  |  | Jan. 01, 2028 |  |  |
Principal Amount |  |  |  | $ 4,000 |  |  |
Investments at cost |  |  |  | 3,949 |  |  |
Investments at fair value |  |  |  | $ 3,949 |  |  |
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.85% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,951 |  |  |
Investments at fair value |  |  |  | $ 3,834 |  |  |
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 1.85% |  |  |
Maturity Date |  |  |  | Oct. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,474 |  |  |
Investments at fair value |  |  |  | 1,916 |  |  |
Investment, Unaffiliated Issuer [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 26 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 10,690 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,885 |  |  |
Investments at cost |  |  |  | 2,853 |  |  |
Investments at fair value |  |  |  | $ 2,777 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,885 |  |  |
Investments at cost |  |  |  | 2,823 |  |  |
Investments at fair value |  |  |  | 2,750 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 311 |  | 311 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 26,444 |  | 26,442 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,442 |  |  |
Investments at cost |  |  |  | 1,411 |  |  |
Investments at fair value |  |  |  | $ 1,374 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Feb. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,885 |  |  |
Investments at cost |  |  |  | 2,821 |  |  |
Investments at fair value |  |  |  | $ 2,748 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Feb. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,885 |  |  |
Investments at cost |  |  |  | 2,821 |  |  |
Investments at fair value |  |  |  | $ 2,748 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,442 |  |  |
Investments at cost |  |  |  | 1,408 |  |  |
Investments at fair value |  |  |  | $ 1,371 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,442 |  |  |
Investments at cost |  |  |  | 1,408 |  |  |
Investments at fair value |  |  |  | $ 1,371 |  |  |
Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 8.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 20.00% |  |  |
Maturity Date |  |  |  | Sep. 15, 2022 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,500 |  |  |
Investments at fair value |  |  |  | $ 2,500 |  |  |
Investment, Unaffiliated Issuer [Member] | Corinth Medtech, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.25% |  |  |
Margin |  |  |  | 5.25% |  |  |
Floor |  |  |  | 8.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 20.00% |  |  |
Maturity Date |  |  |  | Sep. 15, 2022 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,500 |  |  |
Investments at fair value |  |  |  | $ 2,500 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,605 |  | 3,478 |  |  |
Investments at fair value |  | $ 3,605 |  | $ 3,478 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 1,250 |  | $ 1,250 |  |  |
Investments at cost |  | 1,241 |  | 1,238 |  |  |
Investments at fair value |  | 1,241 |  | 1,238 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 92 |  | 56 |  |  |
Investments at fair value |  | $ 279 |  | $ 233 |  |  |
Number of Shares (in shares) |  | 37,294 |  | 31,966 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,723 |  | 3,715 |  |  |
Investments at fair value |  | $ 3,723 |  | $ 3,715 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 1,250 |  | $ 1,250 |  |  |
Investments at cost |  | 1,241 |  | 1,238 |  |  |
Investments at fair value |  | $ 1,241 |  | $ 1,238 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,723 |  | 3,715 |  |  |
Investments at fair value |  | $ 3,723 |  | $ 3,715 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 1,250 |  | $ 1,250 |  |  |
Investments at cost |  | 1,241 |  | 1,238 |  |  |
Investments at fair value |  | $ 1,241 |  | $ 1,238 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jan. 01, 2028 |  | Jan. 01, 2028 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,709 |  | 3,698 |  |  |
Investments at fair value |  | $ 3,709 |  | $ 3,698 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  | 11.25% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 11.25% |  | 11.25% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jan. 01, 2028 |  | Jan. 01, 2028 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,703 |  | 3,698 |  |  |
Investments at fair value |  | $ 3,703 |  | $ 3,698 |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 11.25% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,709 |  |  |  |  |
Investments at fair value |  | $ 3,709 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 11.25% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,705 |  |  |  |  |
Investments at fair value |  | $ 3,705 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.25% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 11.25% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,705 |  |  |  |  |
Investments at fair value |  | $ 3,705 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.33% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,675 |  |  |  |  |
Investments at fair value |  | $ 3,675 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  |  |  |  |
Margin |  | 6.75% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.33% |  |  |  |  |
Maturity Date |  | Dec. 01, 2026 |  |  |  |  |
Principal Amount |  | $ 3,750 |  |  |  |  |
Investments at cost |  | 3,675 |  |  |  |  |
Investments at fair value |  | 3,675 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 81 |  |  |  |  |
Investments at fair value |  | $ 81 |  |  |  |  |
Number of Shares (in shares) |  | 400,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.50% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,481 |  | 2,385 |  |  |
Investments at fair value |  | $ 2,481 |  | $ 2,385 |  |  |
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.50% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,481 |  | 2,473 |  |  |
Investments at fair value |  | 2,481 |  | 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 47 |  | 47 |  |  |
Investments at fair value |  | $ 15 |  | $ 54 |  |  |
Number of Shares (in shares) |  | 171,370 |  | 159,893 |  |  |
Investment, Unaffiliated Issuer [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.50% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 9.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.50% |  | 3.50% |  |  |
Maturity Date |  | Jun. 01, 2026 |  | Jun. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,962 |  | 4,946 |  |  |
Investments at fair value |  | $ 4,962 |  | $ 4,946 |  |  |
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 11.75% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Jan. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,663 |  | 3,597 |  |  |
Investments at fair value |  | $ 3,663 |  | $ 3,597 |  |  |
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 11.75% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Jan. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,718 |  | 3,706 |  |  |
Investments at fair value |  | 3,718 |  | 3,706 |  |  |
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 59 |  | 40 |  |  |
Investments at fair value |  | $ 230 |  | $ 46 |  |  |
Number of Shares (in shares) |  | 27,036 |  | 19,662 |  |  |
Investment, Unaffiliated Issuer [Member] | Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 41 |  | $ 39 |  |  |
Investments at fair value |  | $ 59 |  | $ 55 |  |  |
Number of Shares (in shares) |  | 61,359 |  | 61,539 |  |  |
Investment, Unaffiliated Issuer [Member] | Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 102 |  | $ 102 |  |  |
Investments at fair value |  | $ 1,379 |  | $ 1,370 |  |  |
Number of Shares (in shares) |  | 82,965 |  | 82,965 |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.59% |  |  |  |  |
Margin |  | 5.09% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 750 |  |  |  |  |
Investments at cost |  | 739 |  |  |  |  |
Investments at fair value |  | $ 739 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.59% |  |  |  |  |
Margin |  | 5.09% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jan. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 50 |  |  |  |  |
Investments at cost |  | 49 |  |  |  |  |
Investments at fair value |  | 49 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 172 |  | $ 153 |  |  |
Investments at fair value |  | $ 176 |  | $ 150 |  |  |
Number of Shares (in shares) |  | 1,730,746 |  | 1,375,727 |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.59% |  |  |  |  |
Margin |  | 5.09% |  |  |  |  |
Floor |  | 10.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 1,067 |  |  |  |  |
Investments at cost |  | 1,052 |  |  |  |  |
Investments at fair value |  | 1,052 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.37% |  |  |
Margin |  |  |  | 8.20% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,625 |  |  |
Investments at cost |  |  |  | 1,610 |  |  |
Investments at fair value |  |  |  | $ 1,610 |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.37% |  |  |
Margin |  |  |  | 8.20% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 108 |  |  |
Investments at cost |  |  |  | 107 |  |  |
Investments at fair value |  |  |  | $ 107 |  |  |
Investment, Unaffiliated Issuer [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.37% |  |  |
Margin |  |  |  | 8.20% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Mar. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,000 |  |  |
Investments at cost |  |  |  | 1,983 |  |  |
Investments at fair value |  |  |  | 1,983 |  |  |
Investment, Unaffiliated Issuer [Member] | Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 138 |  | 139 |  |  |
Investments at fair value |  | $ 3,283 |  | $ 3,265 |  |  |
Number of Shares (in shares) |  | 2,936,535 |  | 2,936,535 |  |  |
Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  | 14.75% |  |  |
Margin |  | 7.25% |  | 7.25% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,470 |  | 3,461 |  |  |
Investments at fair value |  | 3,470 |  | 3,461 |  |  |
Investment, Unaffiliated Issuer [Member] | CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 22 |  | 20 |  |  |
Investments at fair value |  | $ 30 |  | $ 61 |  |  |
Number of Shares (in shares) |  | 75,997 |  | 17,605 |  |  |
Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.50% |  | 4.50% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,726 |  | 3,678 |  |  |
Investments at fair value |  | $ 3,726 |  | $ 3,678 |  |  |
Investment, Unaffiliated Issuer [Member] | Engage3, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.50% |  | 4.50% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,726 |  | 3,718 |  |  |
Investments at fair value |  | $ 3,726 |  | 3,718 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.22% |  |  |  |  |
Margin |  | 4.72% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 1,979 |  |  |  |  |
Investments at cost |  | 1,971 |  |  |  |  |
Investments at fair value |  | $ 1,971 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.22% |  |  |  |  |
Margin |  | 4.72% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 1,979 |  |  |  |  |
Investments at cost |  | 1,972 |  |  |  |  |
Investments at fair value |  | 1,972 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 176 |  | 176 |  |  |
Investments at fair value |  | $ 269 |  | $ 263 |  |  |
Number of Shares (in shares) |  | 110,402 |  | 110,402 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 355 |  | $ 356 |  |  |
Investments at fair value |  | $ 356 |  | $ 356 |  |  |
Number of Shares (in shares) |  | 32,831 |  | 32,831 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.22% |  |  |  |  |
Margin |  | 4.72% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Nov. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,943 |  |  |  |  |
Investments at fair value |  | $ 4,943 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.07% |  |  |
Margin |  |  |  | 7.90% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jun. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,979 |  |  |
Investments at cost |  |  |  | 1,962 |  |  |
Investments at fair value |  |  |  | $ 1,962 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.22% |  |  |  |  |
Margin |  | 4.72% |  |  |  |  |
Floor |  | 9.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | May 01, 2026 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,939 |  |  |  |  |
Investments at fair value |  | 4,939 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.07% |  |  |
Margin |  |  |  | 7.90% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jun. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,979 |  |  |
Investments at cost |  |  |  | 1,963 |  |  |
Investments at fair value |  |  |  | $ 1,963 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.07% |  |  |
Margin |  |  |  | 7.90% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,923 |  |  |
Investments at fair value |  |  |  | $ 4,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.07% |  |  |
Margin |  |  |  | 7.90% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,912 |  |  |
Investments at fair value |  |  |  | $ 4,912 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 490 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 217,726 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 7,000 |  |  |  |  |
Investments at cost |  | 6,677 |  |  |  |  |
Investments at fair value |  | $ 6,677 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,459 |  |  |  |  |
Investments at fair value |  | 3,459 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 167 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 85,066 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,459 |  |  |  |  |
Investments at fair value |  | $ 3,459 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,750 |  |  |  |  |
Investments at cost |  | 2,708 |  |  |  |  |
Investments at fair value |  | 2,708 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 7,000 |  |  |
Investments at cost |  |  |  | 6,619 |  |  |
Investments at fair value |  |  |  | $ 6,619 |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,448 |  |  |
Investments at fair value |  |  |  | 3,448 |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 160 |  |  |
Investments at fair value |  |  |  | $ 170 |  |  |
Number of Shares (in shares) |  |  |  | 80,544 |  |  |
Investment, Unaffiliated Issuer [Member] | BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.50% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2027 |  |  |
Principal Amount |  |  |  | $ 3,500 |  |  |
Investments at cost |  |  |  | 3,448 |  |  |
Investments at fair value |  |  |  | 3,448 |  |  |
Investment, Unaffiliated Issuer [Member] | Corvium, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 53 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 661,956 |  |  |
Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Communications Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 92 |  | $ 92 |  |  |
Investments at fair value |  | $ 139 |  | $ 173 |  |  |
Number of Shares (in shares) |  | 598,850 |  | 598,850 |  |  |
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Aug. 01, 2025 |  | Aug. 01, 2025 |  |  |
Principal Amount |  | $ 1,833 |  | $ 2,500 |  |  |
Investments at cost |  | 1,821 |  | 2,482 |  |  |
Investments at fair value |  | $ 1,821 |  | $ 2,482 |  |  |
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Aug. 01, 2025 |  | Aug. 01, 2025 |  |  |
Principal Amount |  | $ 1,833 |  | $ 2,500 |  |  |
Investments at cost |  | 1,821 |  | 2,482 |  |  |
Investments at fair value |  | 1,821 |  | 2,482 |  |  |
Investment, Unaffiliated Issuer [Member] | Clara Foods Co [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 31 |  | 30 |  |  |
Investments at fair value |  | $ 128 |  | $ 125 |  |  |
Number of Shares (in shares) |  | 46,745 |  | 46,745 |  |  |
Investment, Unaffiliated Issuer [Member] | Imunon, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 65 |  | $ 66 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 19,671 |  | 16,502 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 2,500 |  |  |
Investments at cost |  | 4,951 |  | 2,463 |  |  |
Investments at fair value |  | $ 4,951 |  | $ 2,463 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 5,000 |  |  |
Investments at cost |  | 2,475 |  | 4,927 |  |  |
Investments at fair value |  | 2,475 |  | 4,927 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 214 |  | 214 |  |  |
Investments at fair value |  | $ 371 |  | $ 361 |  |  |
Number of Shares (in shares) |  | 681 |  | 681 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,948 |  | 4,924 |  |  |
Investments at fair value |  | $ 4,948 |  | $ 4,924 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | May 01, 2026 |  | May 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,474 |  | 2,462 |  |  |
Investments at fair value |  | $ 2,474 |  | $ 2,462 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 11.75% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | Dec. 01, 2026 |  | Dec. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,926 |  | 4,900 |  |  |
Investments at fair value |  | $ 4,926 |  | $ 4,900 |  |  |
Investment, Unaffiliated Issuer [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 11.75% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.75% |  | 2.75% |  |  |
Maturity Date |  | Dec. 01, 2026 |  | Dec. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,463 |  | 2,450 |  |  |
Investments at fair value |  | $ 2,463 |  | $ 2,450 |  |  |
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,647 |  |  |  |  |
Investments at fair value |  | $ 9,647 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,921 |  |  |  |  |
Investments at fair value |  | 4,921 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 189 |  |  |  |  |
Investments at fair value |  | $ 191 |  |  |  |  |
Number of Shares (in shares) |  | 652,250 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,921 |  |  |  |  |
Investments at fair value |  | $ 4,921 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Elligo Health Research, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,921 |  |  |  |  |
Investments at fair value |  | 4,921 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,966 |  |  |
Investments at fair value |  |  |  | $ 4,966 |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,966 |  |  |
Investments at fair value |  |  |  | 4,966 |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 93 |  | 93 |  |  |
Investments at fair value |  | $ 0 |  | $ 64 |  |  |
Number of Shares (in shares) |  | 20,000 |  | 20,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,000 |  |  |
Investments at cost |  |  |  | 2,979 |  |  |
Investments at fair value |  |  |  | $ 2,979 |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Dec. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 1,000 |  |  |
Investments at cost |  |  |  | 976 |  |  |
Investments at fair value |  |  |  | $ 976 |  |  |
Investment, Unaffiliated Issuer [Member] | Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Feb. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 1,000 |  |  |
Investments at cost |  |  |  | 977 |  |  |
Investments at fair value |  |  |  | $ 977 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 13.50% |  |  |
Margin |  | 3.50% |  | 6.50% |  |  |
Floor |  | 11.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 8.00% |  | 8.00% |  |  |
Maturity Date |  | Sep. 01, 2027 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,295 |  | 2,476 |  |  |
Investments at fair value |  | $ 2,295 |  | $ 2,476 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 13.50% |  |  |
Margin |  | 3.50% |  | 6.50% |  |  |
Floor |  | 11.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 8.00% |  | 8.00% |  |  |
Maturity Date |  | Sep. 01, 2027 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,471 |  | 2,476 |  |  |
Investments at fair value |  | 2,471 |  | 2,476 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 275 |  | 98 |  |  |
Investments at fair value |  | $ 304 |  | $ 123 |  |  |
Number of Shares (in shares) |  | 2,637,043 |  | 605,313 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 13.50% |  |  |
Margin |  | 3.50% |  | 6.50% |  |  |
Floor |  | 11.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 8.00% |  | 8.00% |  |  |
Maturity Date |  | Sep. 01, 2027 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 2,500 |  |  |
Investments at cost |  | 4,943 |  | 2,476 |  |  |
Investments at fair value |  | $ 4,943 |  | $ 2,476 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 13.50% |  |  |
Margin |  | 3.50% |  | 6.50% |  |  |
Floor |  | 11.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 8.00% |  | 8.00% |  |  |
Maturity Date |  | Sep. 01, 2027 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 2,500 |  |  |
Investments at cost |  | 4,943 |  | 2,453 |  |  |
Investments at fair value |  | $ 4,943 |  | $ 2,453 |  |  |
Investment, Unaffiliated Issuer [Member] | Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 8.00% |  |  |
Maturity Date |  |  |  | May 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,455 |  |  |
Investments at fair value |  |  |  | $ 2,455 |  |  |
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 10,000 |  | $ 10,000 |  |  |
Investments at cost |  | 9,877 |  | 9,826 |  |  |
Investments at fair value |  | $ 9,877 |  | $ 9,826 |  |  |
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 10,000 |  | $ 10,000 |  |  |
Investments at cost |  | 9,877 |  | 9,826 |  |  |
Investments at fair value |  | 9,877 |  | 9,826 |  |  |
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 273 |  | 273 |  |  |
Investments at fair value |  | $ 124 |  | $ 296 |  |  |
Number of Shares (in shares) |  | 639,918 |  | 639,918 |  |  |
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,939 |  | 4,913 |  |  |
Investments at fair value |  | $ 4,939 |  | $ 4,913 |  |  |
Investment, Unaffiliated Issuer [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,939 |  | 4,913 |  |  |
Investments at fair value |  | $ 4,939 |  | $ 4,913 |  |  |
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2027 |  | May 01, 2027 |  |  |
Principal Amount |  | $ 6,250 |  | $ 6,250 |  |  |
Investments at cost |  | 6,193 |  | 6,077 |  |  |
Investments at fair value |  | $ 6,193 |  | $ 6,077 |  |  |
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.25% |  | 12.25% |  |  |
Margin |  | 4.75% |  | 4.75% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | May 01, 2027 |  | May 01, 2027 |  |  |
Principal Amount |  | $ 6,250 |  | $ 6,250 |  |  |
Investments at cost |  | 6,193 |  | 6,177 |  |  |
Investments at fair value |  | 6,193 |  | 6,177 |  |  |
Investment, Unaffiliated Issuer [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 50 |  | 51 |  |  |
Investments at fair value |  | $ 60 |  | $ 60 |  |  |
Number of Shares (in shares) |  | 48,076 |  | 48,077 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Apr. 01, 2028 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,678 |  | 3,697 |  |  |
Investments at fair value |  | $ 3,678 |  | $ 3,697 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Apr. 01, 2028 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,692 |  | 3,717 |  |  |
Investments at fair value |  | 3,692 |  | 3,717 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 175 |  | 126 |  |  |
Investments at fair value |  | $ 322 |  | $ 268 |  |  |
Number of Shares (in shares) |  | 46,311 |  | 35,906 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Apr. 01, 2028 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 7,500 |  | $ 7,500 |  |  |
Investments at cost |  | 7,374 |  | 7,424 |  |  |
Investments at fair value |  | $ 7,374 |  | $ 7,424 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Apr. 01, 2028 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,687 |  | 3,712 |  |  |
Investments at fair value |  | $ 3,687 |  | $ 3,712 |  |  |
Investment, Unaffiliated Issuer [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Apr. 01, 2028 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,687 |  | 3,712 |  |  |
Investments at fair value |  | 3,687 |  | 3,712 |  |  |
Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 61 |  |  |  |  |
Investments at fair value |  | $ 346 |  |  |  |  |
Number of Shares (in shares) |  | 7,097,792 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medsphere Systems Corporation [Member] | Software, Healthcare Information and Service [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 60 |  |  |
Investments at fair value |  |  |  | $ 359 |  |  |
Number of Shares (in shares) |  |  |  | 7,097,792 |  |  |
Investment, Unaffiliated Issuer [Member] | Embody, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.00% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 28.00% |  |  |
Maturity Date |  |  |  | Aug. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,482 |  |  |
Investments at fair value |  |  |  | 2,482 |  |  |
Investment, Unaffiliated Issuer [Member] | Aterian, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 195 |  | 195 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 76,923 |  | 76,923 |  |  |
Investment, Unaffiliated Issuer [Member] | Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 146 |  | $ 146 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 16,611 |  | 252,161 |  |  |
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,642 |  |  |  |  |
Investments at fair value |  | $ 4,642 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.75% |  |  |  |  |
Margin |  | 3.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,912 |  |  |  |  |
Investments at fair value |  | 4,912 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 163 |  |  |  |  |
Investments at fair value |  | $ 167 |  |  |  |  |
Number of Shares (in shares) |  | 150,353 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Oct. 01, 2024 |  | Oct. 01, 2024 |  |  |
Principal Amount |  | $ 2,771 |  | $ 3,208 |  |  |
Investments at cost |  | 2,733 |  | 3,143 |  |  |
Investments at fair value |  | $ 2,733 |  | $ 3,143 |  |  |
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Jun. 01, 2025 |  | Jun. 01, 2025 |  |  |
Principal Amount |  | $ 1,000 |  | $ 1,000 |  |  |
Investments at cost |  | 982 |  | 974 |  |  |
Investments at fair value |  | 982 |  | 974 |  |  |
Investment, Unaffiliated Issuer [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 124 |  | 124 |  |  |
Investments at fair value |  | $ 59 |  | $ 113 |  |  |
Number of Shares (in shares) |  | 317,647 |  | 317,647 |  |  |
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,476 |  |  |
Investments at fair value |  |  |  | $ 2,476 |  |  |
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,473 |  |  |
Investments at fair value |  |  |  | 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | F-Star Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 35 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 21,120 |  |  |
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 12.75% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,716 |  | 3,630 |  |  |
Investments at fair value |  | $ 3,716 |  | $ 3,630 |  |  |
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 12.75% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 8.50% |  | 8.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Nov. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,478 |  | 2,469 |  |  |
Investments at fair value |  | 2,478 |  | 2,469 |  |  |
Investment, Unaffiliated Issuer [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 64 |  | 64 |  |  |
Investments at fair value |  | $ 165 |  | $ 162 |  |  |
Number of Shares (in shares) |  | 103,679 |  | 103,679 |  |  |
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2025 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 3,500 |  | $ 5,000 |  |  |
Investments at cost |  | 3,399 |  | 4,857 |  |  |
Investments at fair value |  | $ 3,365 |  | $ 4,857 |  |  |
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Jul. 01, 2025 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 1,750 |  | $ 2,500 |  |  |
Investments at cost |  | 1,699 |  | 2,430 |  |  |
Investments at fair value |  | 1,684 |  | 2,430 |  |  |
Investment, Unaffiliated Issuer [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 366 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 47,452 |  |  |
Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 68 |  | $ 68 |  |  |
Investments at fair value |  | $ 1,060 |  | $ 1,069 |  |  |
Number of Shares (in shares) |  | 268,591 |  | 268,591 |  |  |
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 10,000 |  | $ 10,000 |  |  |
Investments at cost |  | 9,898 |  | 9,701 |  |  |
Investments at fair value |  | $ 9,898 |  | $ 9,701 |  |  |
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,712 |  | 3,697 |  |  |
Investments at fair value |  | 3,712 |  | 3,697 |  |  |
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 162 |  | 160 |  |  |
Investments at fair value |  | $ 667 |  | $ 3,024 |  |  |
Number of Shares (in shares) |  | 299,848 |  | 299,848 |  |  |
Investment, Unaffiliated Issuer [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.75% |  | 3.75% |  |  |
Maturity Date |  | Sep. 01, 2026 |  | Sep. 01, 2026 |  |  |
Principal Amount |  | $ 3,750 |  | $ 3,750 |  |  |
Investments at cost |  | 3,712 |  | 3,697 |  |  |
Investments at fair value |  | 3,712 |  | $ 3,697 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] |  |  |  |  |  |  |
Investments at fair value |  | $ 4,934 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.00% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,960 |  | 4,939 |  |  |
Investments at fair value |  | $ 4,960 |  | $ 4,939 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.00% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,960 |  | 4,939 |  |  |
Investments at fair value |  | 4,960 |  | 4,939 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 194 |  | 194 |  |  |
Investments at fair value |  | $ 395 |  | $ 385 |  |  |
Number of Shares (in shares) |  | 809,931 |  | 809,931 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.00% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,956 |  | 4,933 |  |  |
Investments at fair value |  | $ 4,956 |  | $ 4,933 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.00% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,956 |  | 4,933 |  |  |
Investments at fair value |  | $ 4,956 |  | $ 4,933 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.50% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Jan. 01, 2027 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,934 |  | 4,913 |  |  |
Investments at fair value |  | $ 4,934 |  | $ 4,913 |  |  |
Investment, Unaffiliated Issuer [Member] | Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.50% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Jan. 01, 2027 |  | Jan. 01, 2027 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | $ 4,934 |  | 4,913 |  |  |
Investments at fair value |  |  |  | $ 4,913 |  |  |
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.50% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 5.00% |  | 5.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2027 |  | Mar. 01, 2027 |  |  |
Principal Amount |  | $ 2,000 |  | $ 2,000 |  |  |
Investments at cost |  | 1,335 |  | 1,082 |  |  |
Investments at fair value |  | $ 1,335 |  | $ 1,082 |  |  |
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  | 12.50% |  |  |
Margin |  | 5.00% |  | 5.00% |  |  |
Floor |  | 5.00% |  | 5.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Mar. 01, 2027 |  | Mar. 01, 2027 |  |  |
Principal Amount |  | $ 3,000 |  | $ 3,000 |  |  |
Investments at cost |  | 2,003 |  | 1,623 |  |  |
Investments at fair value |  | 2,003 |  | 1,623 |  |  |
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,945 |  | 2,947 |  |  |
Investments at fair value |  | $ 2,676 |  | $ 2,947 |  |  |
Number of Shares (in shares) |  | 1,312,500 |  | 1,312,500 |  |  |
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 11.00% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 7.78% |  | 7.78% |  |  |
Maturity Date |  | Feb. 01, 2028 |  | Feb. 01, 2028 |  |  |
Principal Amount |  | $ 2,813 |  | $ 2,813 |  |  |
Investments at cost |  | 2,813 |  | 2,813 |  |  |
Investments at fair value |  | $ 2,813 |  | $ 2,813 |  |  |
Investment, Unaffiliated Issuer [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 11.00% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 7.78% |  | 7.78% |  |  |
Maturity Date |  | Feb. 01, 2028 |  | Feb. 01, 2028 |  |  |
Principal Amount |  | $ 2,813 |  | $ 2,813 |  |  |
Investments at cost |  | 2,813 |  | 2,813 |  |  |
Investments at fair value |  | $ 2,813 |  | $ 2,813 |  |  |
Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 1.00% |  | 1.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,975 |  | 4,966 |  |  |
Investments at fair value |  | $ 4,975 |  | $ 4,966 |  |  |
Investment, Unaffiliated Issuer [Member] | Spineology, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 1.00% |  | 1.00% |  |  |
Maturity Date |  | Apr. 01, 2026 |  | Apr. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,487 |  | 2,481 |  |  |
Investments at fair value |  | $ 2,487 |  | $ 2,481 |  |  |
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.00% |  | 14.00% |  |  |
Margin |  | 6.50% |  | 6.50% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Mar. 01, 2026 |  | Mar. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,965 |  | 4,947 |  |  |
Investments at fair value |  | $ 4,965 |  | $ 4,947 |  |  |
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.00% |  | 14.00% |  |  |
Margin |  | 6.50% |  | 6.50% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Mar. 01, 2026 |  | Mar. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,483 |  | 2,474 |  |  |
Investments at fair value |  | 2,483 |  | 2,474 |  |  |
Investment, Unaffiliated Issuer [Member] | Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 32 |  | 34 |  |  |
Investments at fair value |  | $ 43 |  | $ 41 |  |  |
Number of Shares (in shares) |  | 101,308 |  | 101,308 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 4,667 |  |  |  |  |
Investments at cost |  | 4,594 |  |  |  |  |
Investments at fair value |  | $ 4,594 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 4,667 |  |  |  |  |
Investments at cost |  | 4,594 |  |  |  |  |
Investments at fair value |  | 4,594 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 487 |  | $ 399 |  |  |
Investments at fair value |  | $ 205 |  | $ 648 |  |  |
Number of Shares (in shares) |  | 345,327 |  | 203,017 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 2,333 |  |  |  |  |
Investments at cost |  | 2,286 |  |  |  |  |
Investments at fair value |  | $ 2,286 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 4,667 |  |  |
Investments at cost |  |  |  | 4,597 |  |  |
Investments at fair value |  |  |  | $ 4,597 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 2,333 |  |  |  |  |
Investments at cost |  | 2,286 |  |  |  |  |
Investments at fair value |  | $ 2,286 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 4,667 |  |  |
Investments at cost |  |  |  | 4,597 |  |  |
Investments at fair value |  |  |  | $ 4,597 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 2,333 |  |  |  |  |
Investments at cost |  | 2,282 |  |  |  |  |
Investments at fair value |  | $ 2,282 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,333 |  |  |
Investments at cost |  |  |  | 2,280 |  |  |
Investments at fair value |  |  |  | $ 2,280 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.86% |  |  |  |  |
Margin |  | 5.36% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.50% |  |  |  |  |
Maturity Date |  | Dec. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 2,333 |  |  |  |  |
Investments at cost |  | 2,282 |  |  |  |  |
Investments at fair value |  | 2,282 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,333 |  |  |
Investments at cost |  |  |  | 2,280 |  |  |
Investments at fair value |  |  |  | $ 2,280 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,333 |  |  |
Investments at cost |  |  |  | 2,274 |  |  |
Investments at fair value |  |  |  | $ 2,274 |  |  |
Investment, Unaffiliated Issuer [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, LIBOR Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.67% |  |  |
Margin |  |  |  | 8.50% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.50% |  |  |
Maturity Date |  |  |  | Dec. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,333 |  |  |
Investments at cost |  |  |  | 2,274 |  |  |
Investments at fair value |  |  |  | 2,274 |  |  |
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,000 |  | 2,000 |  |  |
Investments at fair value |  | $ 1,700 |  | $ 1,700 |  |  |
Number of Shares (in shares) |  | 392,651 |  | 392,651 |  |  |
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Royalty Agreement [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 1,200 |  | $ 1,200 |  |  |
Investments at fair value |  | $ 1,100 |  | $ 1,100 |  |  |
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,946 |  |  |
Investments at fair value |  |  |  | $ 4,946 |  |  |
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,473 |  |  |
Investments at fair value |  |  |  | 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 67 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 39,774 |  |  |
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,947 |  |  |
Investments at fair value |  |  |  | $ 4,947 |  |  |
Investment, Unaffiliated Issuer [Member] | IMV Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 5.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,947 |  |  |
Investments at fair value |  |  |  | $ 4,947 |  |  |
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 4,500 |  | $ 5,000 |  |  |
Investments at cost |  | 4,434 |  | 4,914 |  |  |
Investments at fair value |  | $ 4,434 |  | $ 4,914 |  |  |
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 2,250 |  | $ 2,500 |  |  |
Investments at cost |  | 2,217 |  | 2,457 |  |  |
Investments at fair value |  | 2,217 |  | 2,457 |  |  |
Investment, Unaffiliated Issuer [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 264 |  | 264 |  |  |
Investments at fair value |  | $ 127 |  | $ 37 |  |  |
Number of Shares (in shares) |  | 318,181 |  | 318,181 |  |  |
Investment, Unaffiliated Issuer [Member] | ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Royalty Agreement [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 0 |  | $ 0 |  |  |
Investments at fair value |  | $ 0 |  | $ 200 |  |  |
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 12.25% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,464 |  | 3,349 |  |  |
Investments at fair value |  | $ 3,464 |  | $ 3,349 |  |  |
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  | 12.25% |  |  |
Margin |  | 5.25% |  | 5.25% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Jul. 01, 2027 |  | Jul. 01, 2027 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,464 |  | 3,454 |  |  |
Investments at fair value |  | 3,464 |  | 3,454 |  |  |
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 71 |  | 71 |  |  |
Investments at fair value |  | $ 40 |  | $ 83 |  |  |
Number of Shares (in shares) |  | 135,484 |  | 135,484 |  |  |
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,453 |  |  |  |  |
Investments at fair value |  | $ 3,453 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.75% |  |  |  |  |
Margin |  | 5.25% |  |  |  |  |
Floor |  | 9.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 3,500 |  |  |  |  |
Investments at cost |  | 3,453 |  |  |  |  |
Investments at fair value |  | $ 3,453 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.00% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 14.25% |  | 9.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 3.00% |  |  |
Maturity Date |  | Nov. 01, 2026 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,418 |  | 2,396 |  |  |
Investments at fair value |  | $ 2,350 |  | $ 2,396 |  |  |
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  | 13.00% |  |  |
Margin |  | 6.00% |  | 6.00% |  |  |
Floor |  | 14.25% |  | 12.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 3.00% |  |  |
Maturity Date |  | Dec. 01, 2026 |  | Dec. 01, 2026 |  |  |
Principal Amount |  | $ 1,250 |  | $ 1,250 |  |  |
Investments at cost |  | 1,236 |  | 1,231 |  |  |
Investments at fair value |  | 1,201 |  | 1,231 |  |  |
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 43 |  | 40 |  |  |
Investments at fair value |  | $ 1 |  | $ 44 |  |  |
Number of Shares (in shares) |  | 85,543 |  | 80,197 |  |  |
Investment, Unaffiliated Issuer [Member] | Lytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.50% |  |  |  |  |
Margin |  | 6.00% |  |  |  |  |
Floor |  | 14.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 1,000 |  |  |  |  |
Investments at cost |  | 993 |  |  |  |  |
Investments at fair value |  | $ 966 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,226 |  |  |  |  |
Investments at fair value |  | $ 2,226 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 12.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Aug. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,455 |  |  |  |  |
Investments at fair value |  | 2,455 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 194 |  |  |  |  |
Investments at fair value |  | $ 194 |  |  |  |  |
Number of Shares (in shares) |  | 1,600,002 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | vTv Therapeutics Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 44 |  | $ 44 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 95,293 |  | 95,293 |  |  |
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,210 |  |  |
Investments at cost |  |  |  | 3,151 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.50% |  |  |
Margin |  |  |  | 6.50% |  |  |
Floor |  |  |  | 9.75% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Jan. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,963 |  |  |
Investments at cost |  |  |  | 2,886 |  |  |
Investments at fair value |  |  |  | 0 |  |  |
Investment, Unaffiliated Issuer [Member] | Interior Define, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 103 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 553,710 |  |  |
Investment, Unaffiliated Issuer [Member] | Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 72 |  | $ 72 |  |  |
Investments at fair value |  | $ 17 |  | $ 3 |  |  |
Number of Shares (in shares) |  | 126,000 |  | 126,000 |  |  |
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 4,000 |  | $ 5,000 |  |  |
Investments at cost |  | 3,975 |  | 4,954 |  |  |
Investments at fair value |  | $ 3,975 |  | $ 4,954 |  |  |
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.25% |  | 14.25% |  |  |
Margin |  | 6.75% |  | 6.75% |  |  |
Floor |  | 10.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Oct. 01, 2025 |  | Oct. 01, 2025 |  |  |
Principal Amount |  | $ 2,000 |  | $ 2,500 |  |  |
Investments at cost |  | 1,987 |  | 2,477 |  |  |
Investments at fair value |  | 1,987 |  | 2,477 |  |  |
Investment, Unaffiliated Issuer [Member] | MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 29 |  | 29 |  |  |
Investments at fair value |  | $ 63 |  | $ 37 |  |  |
Number of Shares (in shares) |  | 250 |  | 143 |  |  |
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,774 |  |  |  |  |
Investments at fair value |  | $ 4,774 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,910 |  |  |  |  |
Investments at fair value |  | 4,910 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 223 |  |  |  |  |
Investments at fair value |  | $ 223 |  |  |  |  |
Number of Shares (in shares) |  | 948,275 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,910 |  |  |  |  |
Investments at fair value |  | $ 4,910 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,910 |  |  |  |  |
Investments at fair value |  | 4,910 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | AccuVein Inc [Member] | Medical Device Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 24 |  | $ 24 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 1,175 |  | 1,175 |  |  |
Investment, Unaffiliated Issuer [Member] | Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 11.00% |  | 10.00% |  |  |
Margin |  | 2.50% |  | 6.75% |  |  |
Floor |  | 8.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 0.00% |  | 0.00% |  |  |
Maturity Date |  | Sep. 01, 2027 |  | Sep. 01, 2027 |  |  |
Principal Amount |  | $ 2,598 |  | $ 2,500 |  |  |
Investments at cost |  | 2,589 |  | 2,588 |  |  |
Investments at fair value |  | $ 2,351 |  | $ 2,279 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 5,547 |  | $ 5,000 |  |  |
Investments at cost |  | 5,505 |  | 4,943 |  |  |
Investments at fair value |  | $ 4,894 |  | $ 4,715 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 2,219 |  | $ 2,000 |  |  |
Investments at cost |  | 2,204 |  | 1,981 |  |  |
Investments at fair value |  | 1,960 |  | 1,890 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 197 |  |  |
Investments at fair value |  |  |  | $ 17 |  |  |
Number of Shares (in shares) |  |  |  | 1,261,253 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Preferred and Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 197 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 1,237,370 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 2,774 |  | $ 2,500 |  |  |
Investments at cost |  | 2,759 |  | 2,477 |  |  |
Investments at fair value |  | $ 2,453 |  | $ 2,363 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 3,328 |  | $ 3,000 |  |  |
Investments at cost |  | 3,310 |  | 2,971 |  |  |
Investments at fair value |  | $ 2,943 |  | $ 2,835 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 2,774 |  | $ 2,500 |  |  |
Investments at cost |  | 2,747 |  | 2,459 |  |  |
Investments at fair value |  | $ 2,443 |  | $ 2,345 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 2,774 |  | $ 2,500 |  |  |
Investments at cost |  | 2,747 |  | 2,459 |  |  |
Investments at fair value |  | $ 2,443 |  | $ 2,345 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 5,547 |  | $ 5,000 |  |  |
Investments at cost |  | 5,493 |  | 4,914 |  |  |
Investments at fair value |  | $ 4,884 |  | $ 4,688 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 12.75% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.00% |  | 9.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.25% |  | 2.00% |  |  |
Maturity Date |  | Oct. 31, 2023 |  | Dec. 30, 2022 |  |  |
Principal Amount |  | $ 2,774 |  | $ 2,500 |  |  |
Investments at cost |  | 2,746 |  | 2,456 |  |  |
Investments at fair value |  | 2,441 |  | 2,342 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Technology Sector [Member] | Preferred Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 89 |  |  |  |  |
Investments at fair value |  | $ 89 |  |  |  |  |
Number of Shares (in shares) |  | 2,688,971 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 66 |  | 64 |  |  |
Investments at fair value |  | $ 1,210 |  | $ 1,200 |  |  |
Number of Shares (in shares) |  | 1,818,183 |  | 1,818,183 |  |  |
Investment, Unaffiliated Issuer [Member] | CZV, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 81 |  |  |  |  |
Investments at fair value |  | $ 81 |  |  |  |  |
Number of Shares (in shares) |  | 65,569 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Consumer-related Technologies [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 253 |  | $ 253 |  |  |
Investments at fair value |  | $ 30 |  | $ 57 |  |  |
Number of Shares (in shares) |  | 87,082 |  | 87,082 |  |  |
Investment, Unaffiliated Issuer [Member] | Rocket Pharmaceuticals Corporation [Member] | Biotechnology Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 17 |  |  |
Investments at fair value |  |  |  | $ 14 |  |  |
Number of Shares (in shares) |  |  |  | 7,051 |  |  |
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Aug. 01, 2027 |  | Aug. 01, 2027 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,408 |  | 2,347 |  |  |
Investments at fair value |  | $ 2,408 |  | 2,347 |  |  |
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.25% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Jul. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 1,875 |  |  |  |  |
Investments at cost |  | 1,783 |  |  |  |  |
Investments at fair value |  | 1,783 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 182 |  | 104 |  |  |
Investments at fair value |  | $ 182 |  | $ 104 |  |  |
Number of Shares (in shares) |  | 11,550 |  | 6,600 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 6.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,463 |  |  |
Investments at fair value |  |  |  | $ 2,364 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.75% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 6.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,463 |  |  |
Investments at fair value |  |  |  | 2,364 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 48 |  | 48 |  |  |
Investments at fair value |  | $ 10 |  | $ 31 |  |  |
Number of Shares (in shares) |  | 8,800 |  | 27,330 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,466 |  |  |  |  |
Investments at fair value |  | $ 2,344 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Apr. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,466 |  |  |  |  |
Investments at fair value |  | $ 2,344 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 9.00% |  |  |  |  |
Margin |  | 0.00% |  |  |  |  |
Floor |  | 0.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 18.00% |  |  |  |  |
Maturity Date |  | Jun. 30, 2024 |  |  |  |  |
Principal Amount |  | $ 200 |  |  |  |  |
Investments at cost |  | 200 |  |  |  |  |
Investments at fair value |  | $ 190 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  | 14.25% |  |  |
Margin |  | 7.25% |  | 7.25% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 1,700 |  | $ 2,700 |  |  |
Investments at cost |  | 1,683 |  | 2,673 |  |  |
Investments at fair value |  | $ 1,683 |  | $ 2,673 |  |  |
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  | 14.25% |  |  |
Margin |  | 7.25% |  | 7.25% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Mar. 01, 2025 |  | Mar. 01, 2025 |  |  |
Principal Amount |  | $ 1,700 |  | $ 2,700 |  |  |
Investments at cost |  | 1,683 |  | 2,673 |  |  |
Investments at fair value |  | 1,683 |  | 2,673 |  |  |
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 57 |  | 57 |  |  |
Investments at fair value |  | $ 596 |  | $ 429 |  |  |
Number of Shares (in shares) |  | 553,778 |  | 553,778 |  |  |
Investment, Unaffiliated Issuer [Member] | Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  | 14.25% |  |  |
Margin |  | 7.25% |  | 7.25% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Sep. 01, 2025 |  | Sep. 01, 2025 |  |  |
Principal Amount |  | $ 2,300 |  | $ 3,000 |  |  |
Investments at cost |  | 2,277 |  | 2,967 |  |  |
Investments at fair value |  | 2,277 |  | $ 2,967 |  |  |
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 7.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,475 |  |  |
Investments at fair value |  |  |  | $ 2,475 |  |  |
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 7.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,489 |  |  |
Investments at fair value |  |  |  | 2,489 |  |  |
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 86 |  | 84 |  |  |
Investments at fair value |  | $ 1,307 |  | $ 1,864 |  |  |
Number of Shares (in shares) |  | 12,153 |  | 12,153 |  |  |
Investment, Unaffiliated Issuer [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.75% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 7.00% |  |  |
Maturity Date |  |  |  | Nov. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,473 |  |  |
Investments at fair value |  |  |  | 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 9 |  | 8 |  |  |
Investments at fair value |  | $ 83 |  | $ 83 |  |  |
Number of Shares (in shares) |  | 82,974 |  | 82,974 |  |  |
Investment, Unaffiliated Issuer [Member] | Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 325 |  | $ 325 |  |  |
Investments at fair value |  | $ 538 |  | $ 534 |  |  |
Number of Shares (in shares) |  | 6,191 |  | 6,191 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Sep. 01, 2025 |  | Sep. 01, 2025 |  |  |
Principal Amount |  | $ 8,102 |  | $ 7,500 |  |  |
Investments at cost |  | 8,009 |  | 7,371 |  |  |
Investments at fair value |  | $ 6,754 |  | $ 7,371 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Sep. 01, 2025 |  | Sep. 01, 2025 |  |  |
Principal Amount |  | $ 8,102 |  | $ 7,500 |  |  |
Investments at cost |  | 8,009 |  | 7,371 |  |  |
Investments at fair value |  | $ 6,754 |  | 7,371 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 488 |  |  |
Investments at fair value |  |  |  | $ 1,061 |  |  |
Number of Shares (in shares) |  |  |  | 204,832 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Sep. 01, 2025 |  | Sep. 01, 2025 |  |  |
Principal Amount |  | $ 8,102 |  | $ 7,500 |  |  |
Investments at cost |  | 8,009 |  | 7,371 |  |  |
Investments at fair value |  | $ 6,754 |  | $ 7,371 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Jul. 01, 2026 |  | Jul. 01, 2026 |  |  |
Principal Amount |  | $ 5,402 |  | $ 5,000 |  |  |
Investments at cost |  | 5,332 |  | 4,903 |  |  |
Investments at fair value |  | $ 4,496 |  | $ 4,903 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  | 14.50% |  |  |
Margin |  | 7.00% |  | 7.00% |  |  |
Floor |  | 10.25% |  | 10.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 2.50% |  |  |
Maturity Date |  | Jul. 01, 2026 |  | Jul. 01, 2026 |  |  |
Principal Amount |  | $ 5,402 |  | $ 5,000 |  |  |
Investments at cost |  | 5,332 |  | 4,903 |  |  |
Investments at fair value |  | $ 4,496 |  | $ 4,903 |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  |  |  |  |
Margin |  | 7.00% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Sep. 30, 2023 |  |  |  |  |
Principal Amount |  | $ 707 |  |  |  |  |
Investments at cost |  | 707 |  |  |  |  |
Investments at fair value |  | $ 596 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  |  |  |  |
Margin |  | 7.00% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Sep. 30, 2023 |  |  |  |  |
Principal Amount |  | $ 564 |  |  |  |  |
Investments at cost |  | 564 |  |  |  |  |
Investments at fair value |  | $ 475 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  |  |  |  |
Margin |  | 7.00% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Sep. 30, 2023 |  |  |  |  |
Principal Amount |  | $ 281 |  |  |  |  |
Investments at cost |  | 281 |  |  |  |  |
Investments at fair value |  | $ 237 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  |  |  |  |
Margin |  | 7.00% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Sep. 30, 2023 |  |  |  |  |
Principal Amount |  | $ 279 |  |  |  |  |
Investments at cost |  | 279 |  |  |  |  |
Investments at fair value |  | $ 235 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Nexii Building Solutions, Inc1 [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.50% |  |  |  |  |
Margin |  | 7.00% |  |  |  |  |
Floor |  | 10.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.50% |  |  |  |  |
Maturity Date |  | Sep. 30, 2023 |  |  |  |  |
Principal Amount |  | $ 167 |  |  |  |  |
Investments at cost |  | 167 |  |  |  |  |
Investments at fair value |  | $ 141 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 10,000 |  |  |  |  |
Investments at cost |  | 9,814 |  |  |  |  |
Investments at fair value |  | $ 9,814 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,938 |  |  |  |  |
Investments at fair value |  | 4,938 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 115 |  |  |  |  |
Investments at fair value |  | $ 79 |  |  |  |  |
Number of Shares (in shares) |  | 84,037 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.50% |  |  |  |  |
Margin |  | 5.00% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Mar. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,939 |  |  |  |  |
Investments at fair value |  | $ 4,939 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,751 |  |  |  |  |
Investments at fair value |  | $ 4,751 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,451 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 152 |  |  |  |  |
Investments at fair value |  | $ 152 |  |  |  |  |
Number of Shares (in shares) |  | 93,336 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  |  |  |  |
Margin |  | 3.50% |  |  |  |  |
Floor |  | 11.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 5.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,451 |  |  |  |  |
Investments at fair value |  | $ 2,451 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 16.25% |  | 15.25% |  |  |
Margin |  | 7.75% |  | 7.75% |  |  |
Floor |  | 11.00% |  | 11.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 0.00% |  | 0.00% |  |  |
Maturity Date |  | May 01, 2027 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 1,108 |  | $ 2,500 |  |  |
Investments at cost |  | 1,086 |  | 2,473 |  |  |
Investments at fair value |  | $ 872 |  | $ 2,473 |  |  |
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 16.25% |  | 15.25% |  |  |
Margin |  | 7.75% |  | 7.75% |  |  |
Floor |  | 11.00% |  | 11.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 0.00% |  | 0.00% |  |  |
Maturity Date |  | May 01, 2027 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 554 |  | $ 1,250 |  |  |
Investments at cost |  | 543 |  | 1,236 |  |  |
Investments at fair value |  | 436 |  | 1,236 |  |  |
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 32 |  | 32 |  |  |
Investments at fair value |  | $ 0 |  | $ 22 |  |  |
Number of Shares (in shares) |  | 171,081 |  | 171,081 |  |  |
Investment, Unaffiliated Issuer [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 16.25% |  | 15.25% |  |  |
Margin |  | 7.75% |  | 7.75% |  |  |
Floor |  | 11.00% |  | 11.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 0.00% |  | 0.00% |  |  |
Maturity Date |  | May 01, 2027 |  | Jul. 01, 2025 |  |  |
Principal Amount |  | $ 554 |  | $ 1,250 |  |  |
Investments at cost |  | 543 |  | 1,236 |  |  |
Investments at fair value |  | $ 436 |  | $ 1,236 |  |  |
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 10.50% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 8.25% |  | 8.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Oct. 01, 2024 |  | Oct. 01, 2024 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,985 |  | 4,973 |  |  |
Investments at fair value |  | $ 4,985 |  | $ 4,973 |  |  |
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 10.50% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 8.25% |  | 8.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Oct. 01, 2024 |  | Oct. 01, 2024 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,985 |  | 4,973 |  |  |
Investments at fair value |  | 4,985 |  | 4,973 |  |  |
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 69 |  | 69 |  |  |
Investments at fair value |  | $ 213 |  | $ 209 |  |  |
Number of Shares (in shares) |  | 145,483 |  | 145,483 |  |  |
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 10.50% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 8.25% |  | 8.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Oct. 01, 2024 |  | Oct. 01, 2024 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,488 |  | 2,478 |  |  |
Investments at fair value |  | $ 2,488 |  | $ 2,478 |  |  |
Investment, Unaffiliated Issuer [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.00% |  | 10.50% |  |  |
Margin |  | 3.50% |  | 3.50% |  |  |
Floor |  | 8.25% |  | 8.25% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.50% |  | 5.50% |  |  |
Maturity Date |  | Oct. 01, 2024 |  | Oct. 01, 2024 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,488 |  | 2,478 |  |  |
Investments at fair value |  | 2,488 |  | 2,478 |  |  |
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 111 |  |  |  |  |
Investments at fair value |  | $ 36 |  |  |  |  |
Number of Shares (in shares) |  | 5,205 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Preferred Stock [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 8 |  |  |
Investments at fair value |  |  |  | $ 27 |  |  |
Number of Shares (in shares) |  |  |  | 22,313 |  |  |
Investment, Unaffiliated Issuer [Member] | Updater, Inc [Member] | Consumer-related Technologies [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 34 |  | $ 34 |  |  |
Investments at fair value |  | $ 0 |  | $ 42 |  |  |
Number of Shares (in shares) |  | 108,333 |  | 108,333 |  |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 4,722 |  | $ 2,500 |  |  |
Investments at cost |  | 4,678 |  | 2,466 |  |  |
Investments at fair value |  | $ 4,678 |  | $ 2,466 |  |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.00% |  |  |
Margin |  | 5.50% |  | 5.50% |  |  |
Floor |  | 8.75% |  | 8.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 6.00% |  | 6.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 2,361 |  | $ 5,000 |  |  |
Investments at cost |  | 2,339 |  | 4,932 |  |  |
Investments at fair value |  | 2,339 |  | 4,932 |  |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 148 |  | 148 |  |  |
Investments at fair value |  | $ 184 |  | $ 179 |  |  |
Number of Shares (in shares) |  | 4,106,174 |  | 775,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Branded Online, Inc [Member] | Software Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 1,079 |  | $ 1,079 |  |  |
Investments at fair value |  | $ 3 |  | $ 83 |  |  |
Number of Shares (in shares) |  | 5,398 |  | 108,004 |  |  |
Investment, Unaffiliated Issuer [Member] | CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 242 |  | $ 242 |  |  |
Investments at fair value |  | $ 917 |  | $ 909 |  |  |
Number of Shares (in shares) |  | 500,000 |  | 500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 15.75% |  | 14.25% |  |  |
Margin |  | 7.25% |  | 7.25% |  |  |
Floor |  | 10.50% |  | 10.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 3.00% |  |  |
Maturity Date |  | Aug. 01, 2025 |  | Aug. 01, 2025 |  |  |
Principal Amount |  | $ 3,833 |  | $ 5,000 |  |  |
Investments at cost |  | 3,785 |  | 4,932 |  |  |
Investments at fair value |  | 3,785 |  | 4,932 |  |  |
Investment, Unaffiliated Issuer [Member] | Reputation Institute, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 56 |  | 56 |  |  |
Investments at fair value |  | $ 48 |  | $ 39 |  |  |
Number of Shares (in shares) |  | 3,731 |  | 3,731 |  |  |
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 13.32% |  |  |  |  |
Margin |  | 4.82% |  |  |  |  |
Floor |  | 9.25% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 10.36% |  |  |  |  |
Maturity Date |  | Jul. 01, 2025 |  |  |  |  |
Principal Amount |  | $ 3,960 |  |  |  |  |
Investments at cost |  | 3,916 |  |  |  |  |
Investments at fair value |  | 3,916 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 218 |  | $ 221 |  |  |
Investments at fair value |  | $ 236 |  | $ 226 |  |  |
Number of Shares (in shares) |  | 7,972,222 |  | 7,972,222 |  |  |
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.17% |  |  |
Margin |  |  |  | 8.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 10.36% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,960 |  |  |
Investments at cost |  |  |  | 3,898 |  |  |
Investments at fair value |  |  |  | $ 3,898 |  |  |
Investment, Unaffiliated Issuer [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Term Loan, LIBOR Index, Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 12.17% |  |  |
Margin |  |  |  | 8.00% |  |  |
Floor |  |  |  | 9.25% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 10.36% |  |  |
Maturity Date |  |  |  | Jul. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 3,960 |  |  |
Investments at cost |  |  |  | 3,898 |  |  |
Investments at fair value |  |  |  | $ 3,898 |  |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 16.93% |  |  |
Margin |  |  |  | 9.43% |  |  |
Floor |  |  |  | 12.68% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 50.43% |  |  |
Maturity Date |  |  |  | Dec. 31, 2022 |  |  |
Principal Amount |  |  |  | $ 3,295 |  |  |
Investments at cost |  |  |  | 3,295 |  |  |
Investments at fair value |  |  |  | 3,295 |  |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 46 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 82,967 |  |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 230 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 72,638,663 |  |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Preferred Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 2,800 |  |  |  |  |
Investments at fair value |  | $ 1,281 |  |  |  |  |
Number of Shares (in shares) |  | 280,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Silk, Inc [Member] | Data Storage Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 175 |  | $ 234 |  |  |
Investments at fair value |  | $ 153 |  | $ 407 |  |  |
Number of Shares (in shares) |  | 394,110 |  | 442,110 |  |  |
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,952 |  | 4,870 |  |  |
Investments at fair value |  | $ 4,952 |  | $ 4,870 |  |  |
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,952 |  | 4,933 |  |  |
Investments at fair value |  | 4,952 |  | 4,933 |  |  |
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 123 |  | 123 |  |  |
Investments at fair value |  | $ 135 |  | $ 133 |  |  |
Number of Shares (in shares) |  | 309,208 |  | 309,208 |  |  |
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,952 |  | 4,933 |  |  |
Investments at fair value |  | $ 4,952 |  | $ 4,933 |  |  |
Investment, Unaffiliated Issuer [Member] | Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.25% |  | 13.25% |  |  |
Margin |  | 5.75% |  | 5.75% |  |  |
Floor |  | 9.75% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 5.00% |  | 5.00% |  |  |
Maturity Date |  | Aug. 01, 2026 |  | Aug. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 5,000 |  |  |
Investments at cost |  | 4,952 |  | 4,933 |  |  |
Investments at fair value |  | 4,952 |  | 4,933 |  |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 18 |  | 22 |  |  |
Investments at fair value |  | $ 44 |  | $ 312 |  |  |
Number of Shares (in shares) |  | 71,305 |  | 288,115 |  |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Preferred Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 4 |  |  |  |  |
Investments at fair value |  | $ 193 |  |  |  |  |
Number of Shares (in shares) |  | 66,127 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 75 |  | $ 75 |  |  |
Investments at fair value |  | $ 63 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 245,810 |  | 245,810 |  |  |
Investment, Unaffiliated Issuer [Member] | CVRx, Inc [Member] | Medical Device Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 76 |  | $ 76 |  |  |
Investments at fair value |  | $ 272 |  | $ 394 |  |  |
Number of Shares (in shares) |  | 47,410 |  | 47,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 92 |  | $ 92 |  |  |
Investments at fair value |  | $ 336 |  | $ 357 |  |  |
Number of Shares (in shares) |  | 261,721 |  | 261,721 |  |  |
Investment, Unaffiliated Issuer [Member] | Skillshare, Inc [Member] | Internet and Media Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 162 |  | $ 162 |  |  |
Investments at fair value |  | $ 1,216 |  | $ 802 |  |  |
Number of Shares (in shares) |  | 139,074 |  | 139,074 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Software Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  |  |  |  |
Margin |  | 6.25% |  |  |  |  |
Floor |  | 9.50% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.00% |  |  |  |  |
Maturity Date |  | Sep. 01, 2024 |  |  |  |  |
Principal Amount |  | $ 917 |  |  |  |  |
Investments at cost |  | 887 |  |  |  |  |
Investments at fair value |  | $ 887 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Sep. 01, 2024 |  | Sep. 01, 2024 |  |  |
Principal Amount |  | $ 1,833 |  | $ 3,333 |  |  |
Investments at cost |  | 1,807 |  | 3,286 |  |  |
Investments at fair value |  | $ 1,807 |  | $ 3,286 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Sep. 01, 2024 |  | Sep. 01, 2024 |  |  |
Principal Amount |  | $ 1,833 |  | $ 3,333 |  |  |
Investments at cost |  | 1,807 |  | 3,286 |  |  |
Investments at fair value |  | 1,807 |  | 3,286 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 364 |  | 364 |  |  |
Investments at fair value |  | $ 251 |  | $ 243 |  |  |
Number of Shares (in shares) |  | 344,102 |  | 344,102 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Sep. 01, 2024 |  | Sep. 01, 2024 |  |  |
Principal Amount |  | $ 917 |  | $ 1,667 |  |  |
Investments at cost |  | 903 |  | 1,641 |  |  |
Investments at fair value |  | $ 903 |  | $ 1,641 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.75% |  | 13.25% |  |  |
Margin |  | 6.25% |  | 6.25% |  |  |
Floor |  | 9.50% |  | 9.50% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 4.00% |  | 4.00% |  |  |
Maturity Date |  | Sep. 01, 2024 |  | Sep. 01, 2024 |  |  |
Principal Amount |  | $ 917 |  | $ 1,667 |  |  |
Investments at cost |  | 903 |  | 1,641 |  |  |
Investments at fair value |  | $ 903 |  | $ 1,641 |  |  |
Investment, Unaffiliated Issuer [Member] | Liqid, Inc [Member] | Networking Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 6.25% |  |  |
Floor |  |  |  | 9.50% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Sep. 01, 2024 |  |  |
Principal Amount |  |  |  | $ 1,667 |  |  |
Investments at cost |  |  |  | 1,613 |  |  |
Investments at fair value |  |  |  | $ 1,613 |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.50% |  |  |
Margin |  | 4.25% |  | 6.50% |  |  |
Floor |  | 12.00% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 4.00% |  |  |
Maturity Date |  | Jun. 01, 2028 |  | Feb. 01, 2025 |  |  |
Principal Amount |  | $ 2,500 |  | $ 3,500 |  |  |
Investments at cost |  | 2,457 |  | 3,472 |  |  |
Investments at fair value |  | $ 2,457 |  | $ 3,472 |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.50% |  |  |
Margin |  | 4.25% |  | 6.50% |  |  |
Floor |  | 12.00% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 4.00% |  |  |
Maturity Date |  | Jun. 01, 2028 |  | Feb. 01, 2025 |  |  |
Principal Amount |  | $ 3,500 |  | $ 3,500 |  |  |
Investments at cost |  | 3,489 |  | 3,472 |  |  |
Investments at fair value |  | 3,489 |  | $ 3,472 |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 64 |  |  |  |  |
Investments at fair value |  | $ 146 |  |  |  |  |
Number of Shares (in shares) |  | 682 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.50% |  |  |
Margin |  | 4.25% |  | 6.50% |  |  |
Floor |  | 12.00% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 4.00% |  |  |
Maturity Date |  | Jun. 01, 2028 |  | Dec. 01, 2025 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,492 |  | 2,472 |  |  |
Investments at fair value |  | $ 2,492 |  | $ 2,472 |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  | 13.50% |  |  |
Margin |  | 4.25% |  | 6.50% |  |  |
Floor |  | 12.00% |  | 9.75% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 2.50% |  | 4.00% |  |  |
Maturity Date |  | Jun. 01, 2028 |  | Dec. 01, 2025 |  |  |
Principal Amount |  | $ 1,500 |  | $ 2,500 |  |  |
Investments at cost |  | 1,495 |  | 2,472 |  |  |
Investments at fair value |  | 1,495 |  | 2,472 |  |  |
Investment, Unaffiliated Issuer [Member] | Meditrina, Inc [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 83 |  | 83 |  |  |
Investments at fair value |  | $ 104 |  | $ 101 |  |  |
Number of Shares (in shares) |  | 233,993 |  | 233,993 |  |  |
Investment, Unaffiliated Issuer [Member] | Halio, Inc [Member] | Power Management Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 1,585 |  | $ 1,585 |  |  |
Investments at fair value |  | $ 2,901 |  | $ 2,610 |  |  |
Number of Shares (in shares) |  | 5,002,574 |  | 5,002,574 |  |  |
Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Preferred and Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 56 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 6,081 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 56 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 6,081 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,699 |  |  |
Investments at fair value |  |  |  | $ 3,699 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 14.25% |  |  |
Margin |  |  |  | 6.75% |  |  |
Floor |  |  |  | 10.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Apr. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 3,750 |  |  |
Investments at cost |  |  |  | 3,699 |  |  |
Investments at fair value |  |  |  | 3,699 |  |  |
Investment, Unaffiliated Issuer [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 61 |  |  |
Investments at fair value |  |  |  | $ 74 |  |  |
Number of Shares (in shares) |  |  |  | 201,537 |  |  |
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.75% |  |  |
Margin |  | 5.50% |  | 6.75% |  |  |
Floor |  | 14.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 5.00% |  |  |
Maturity Date |  | Oct. 01, 2028 |  | Mar. 01, 2026 |  |  |
Principal Amount |  | $ 5,000 |  | $ 2,500 |  |  |
Investments at cost |  | 4,857 |  | 2,421 |  |  |
Investments at fair value |  | $ 4,857 |  | $ 2,421 |  |  |
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  | 13.75% |  |  |
Margin |  | 5.50% |  | 6.75% |  |  |
Floor |  | 14.00% |  | 10.00% |  |  |
Ceiling |  | 0.00% |  | 0.00% |  |  |
ETP |  | 3.00% |  | 5.00% |  |  |
Maturity Date |  | Oct. 01, 2028 |  | Mar. 01, 2026 |  |  |
Principal Amount |  | $ 2,500 |  | $ 2,500 |  |  |
Investments at cost |  | 2,464 |  | 2,487 |  |  |
Investments at fair value |  | 2,464 |  | 2,487 |  |  |
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 98 |  | 21 |  |  |
Investments at fair value |  | $ 147 |  | $ 69 |  |  |
Number of Shares (in shares) |  | 161,215 |  | 77,828 |  |  |
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | $ 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 14.00% |  |  |  |  |
Margin |  | 5.50% |  |  |  |  |
Floor |  | 14.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.00% |  |  |  |  |
Maturity Date |  | Oct. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | $ 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.50% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 5,000 |  |  |  |  |
Investments at cost |  | 4,768 |  |  |  |  |
Investments at fair value |  | $ 4,768 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.50% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 120 |  |  |  |  |
Investments at fair value |  | $ 122 |  |  |  |  |
Number of Shares (in shares) |  | 345,443 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.50% |  |  |  |  |
Margin |  | 4.00% |  |  |  |  |
Floor |  | 11.75% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 3.50% |  |  |  |  |
Maturity Date |  | Jun. 01, 2027 |  |  |  |  |
Principal Amount |  | $ 2,500 |  |  |  |  |
Investments at cost |  | 2,464 |  |  |  |  |
Investments at fair value |  | 2,464 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | 53 |  | $ 53 |  |  |
Investments at fair value |  | $ 1 |  | $ 1 |  |  |
Number of Shares (in shares) |  | 408 |  | 408 |  |  |
Investment, Unaffiliated Issuer [Member] | E La Carte, Inc [Member] | Software Sector [Member] | Common Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 60 |  | $ 60 |  |  |
Investments at fair value |  | $ 0 |  | $ 3 |  |  |
Number of Shares (in shares) |  | 147,361 |  | 147,361 |  |  |
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 18.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,798 |  |  |
Investments at fair value |  |  |  | $ 4,798 |  |  |
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.00% |  |  |
Margin |  |  |  | 5.50% |  |  |
Floor |  |  |  | 11.00% |  |  |
Ceiling |  |  |  | 18.00% |  |  |
ETP |  |  |  | 3.00% |  |  |
Maturity Date |  |  |  | Dec. 01, 2026 |  |  |
Principal Amount |  |  |  | $ 5,000 |  |  |
Investments at cost |  |  |  | 4,948 |  |  |
Investments at fair value |  |  |  | 4,948 |  |  |
Investment, Unaffiliated Issuer [Member] | Groundspeed Analytics, Inc. [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 6 |  |  |
Investments at fair value |  |  |  | $ 6 |  |  |
Number of Shares (in shares) |  |  |  | 86,300 |  |  |
Investment, Unaffiliated Issuer [Member] | Everstream Holdings, LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 70 |  |  |  |  |
Investments at fair value |  | $ 71 |  |  |  |  |
Number of Shares (in shares) |  | 350,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Revinate Holdings, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 44 |  | $ 46 |  |  |
Investments at fair value |  | $ 103 |  | $ 99 |  |  |
Number of Shares (in shares) |  | 682,034 |  | 682,034 |  |  |
Investment, Unaffiliated Issuer [Member] | Riv Data Corp [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 12 |  |  |
Investments at fair value |  |  |  | $ 296 |  |  |
Number of Shares (in shares) |  |  |  | 321,428 |  |  |
Investment, Unaffiliated Issuer [Member] | SIGNiX, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 225 |  | $ 225 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 186,235 |  | 186,235 |  |  |
Investment, Unaffiliated Issuer [Member] | Skyword, Inc [Member] | Software Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 48 |  |  |
Investments at fair value |  |  |  | $ 1 |  |  |
Number of Shares (in shares) |  |  |  | 301,055 |  |  |
Investment, Unaffiliated Issuer [Member] | Supply Network Visiblity Holdings LLC [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | $ 64 |  |  |
Investments at fair value |  |  |  | $ 83 |  |  |
Number of Shares (in shares) |  |  |  | 682 |  |  |
Investment, Unaffiliated Issuer [Member] | Topia Mobility, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 138 |  | $ 138 |  |  |
Investments at fair value |  | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) |  | 3,049,607 |  | 3,049,607 |  |  |
Investment, Unaffiliated Issuer [Member] | xAd, Inc [Member] | Software Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 177 |  | $ 177 |  |  |
Investments at fair value |  | $ 12 |  | $ 12 |  |  |
Number of Shares (in shares) |  | 4,343,348 |  | 4,343,348 |  |  |
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Oct. 01, 2025 |  |  |
Principal Amount |  |  |  | $ 4,943 |  |  |
Investments at cost |  |  |  | 4,943 |  |  |
Investments at fair value |  |  |  | $ 1,668 |  |  |
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  |  |  | 13.25% |  |  |
Margin |  |  |  | 5.75% |  |  |
Floor |  |  |  | 9.00% |  |  |
Ceiling |  |  |  | 0.00% |  |  |
ETP |  |  |  | 4.00% |  |  |
Maturity Date |  |  |  | Dec. 31, 2025 |  |  |
Principal Amount |  |  |  | $ 2,500 |  |  |
Investments at cost |  |  |  | 2,467 |  |  |
Investments at fair value |  |  |  | 832 |  |  |
Investment, Unaffiliated Issuer [Member] | Secure Transfusion Services, Inc [Member] | Other Healthcare Sector [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |  |
Investments at cost |  |  |  | 47 |  |  |
Investments at fair value |  |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  |  | 77,690 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 39,666 |  | $ 0 |  |  |
Investments at fair value |  | 20,485 | $ 906 | 0 | $ 0 | $ 0 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 34,540 |  |  |  |  |
Investments at fair value |  | 12,000 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 126 |  |  |  |  |
Investments at fair value |  | 0 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Life Science [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,000 |  |  |  |  |
Investments at fair value |  | $ 8,485 |  |  |  |  |
Number of Shares (in shares) |  |  |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 7,778 |  |  |  |  |
Investments at cost |  | 7,672 |  |  |  |  |
Investments at fair value |  | $ 2,666 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 11,667 |  |  |  |  |
Investments at cost |  | 11,509 |  |  |  |  |
Investments at fair value |  | 3,997 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,000 |  |  |  |  |
Investments at fair value |  | $ 8,485 |  |  |  |  |
Number of Shares (in shares) |  | 2,164,502 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index Three [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 4,681 |  |  |  |  |
Investments at cost |  | 4,618 |  |  |  |  |
Investments at fair value |  | $ 1,604 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 4,667 |  |  |  |  |
Investments at cost |  | 4,603 |  |  |  |  |
Investments at fair value |  | $ 1,597 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,111 |  |  |  |  |
Investments at cost |  | 3,069 |  |  |  |  |
Investments at fair value |  | 1,068 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Warrant [Member] |  |  |  |  |  |  |
Investments at cost |  | 126 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 23,196 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.75% |  |  |  |  |
Margin |  | 4.25% |  |  |  |  |
Floor |  | 11.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 4.25% |  |  |  |  |
Maturity Date |  | Jan. 01, 2028 |  |  |  |  |
Principal Amount |  | $ 3,111 |  |  |  |  |
Investments at cost |  | 3,069 |  |  |  |  |
Investments at fair value |  | 1,068 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |  |  |  |
Investments at fair value |  | 0 | 0 | 0 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] | Medical Device Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 0 |  |  |  |  |
Investments at fair value |  | $ 0 |  |  |  |  |
Number of Shares (in shares) |  | 660,537 |  |  |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] |  |  |  |  |  |  |
Investments at fair value | [1] | $ 0 | 906 | 0 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 0 |  |  |  |  |
Investments at fair value |  | $ 408 |  |  |  |  |
Number of Shares (in shares) |  | 600,000 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |  |  |  |
Investments at cost |  | $ 14,216 |  | 0 |  |  |
Investments at fair value |  | 13,145 | 0 | 0 | $ 0 | $ 0 | $ 0
Investment, Affiliated Issuer, Controlled [Member] | Biotechnology Sector [Member] | Other Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 6,154 |  |  |  |  |
Investments at fair value |  | 6,154 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Debt Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 5,251 |  |  |  |  |
Investments at fair value |  | 4,439 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Technology Sector [Member] | Equity Securities [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,811 |  |  |  |  |
Investments at fair value |  | $ 2,552 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.78% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 3,604 |  |  |  |  |
Investments at cost |  | 3,556 |  |  |  |  |
Investments at fair value |  | $ 3,006 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Term Loan, Prime Index Two [Member] |  |  |  |  |  |  |
Cash Rate |  | 12.25% |  |  |  |  |
Margin |  | 3.75% |  |  |  |  |
Floor |  | 12.00% |  |  |  |  |
Ceiling |  | 0.00% |  |  |  |  |
ETP |  | 2.78% |  |  |  |  |
Maturity Date |  | Aug. 01, 2029 |  |  |  |  |
Principal Amount |  | $ 1,719 |  |  |  |  |
Investments at cost |  | 1,695 |  |  |  |  |
Investments at fair value |  | 1,433 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Preferred and Common Stock [Member] |  |  |  |  |  |  |
Investments at cost |  | 2,811 |  |  |  |  |
Investments at fair value |  | $ 2,552 |  |  |  |  |
Number of Shares (in shares) |  | 2,551,596 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |  |  |  |
Investments at fair value |  | $ 6,154 | $ 0 | $ 0 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] | Biotechnology Sector [Member] | Other Investments [Member] |  |  |  |  |  |  |
Investments at cost |  | 6,154 |  |  |  |  |
Investments at fair value |  | $ 6,154 |  |  |  |  |
[1] | As of September 30, 2023, the Company no longer owns 5% or more of the portfolio company.

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_HealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_ConvertibleDebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorinthMedtechIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CorviumIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmbodyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FstarTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanLiborIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImvIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VtvTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InteriorDefineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredAndCommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsInc1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrandedOnlineIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CvrxIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GroundspeedAnalyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RivDataCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkywordIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SecureTransfusionServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |